Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials

SIMPLE SUMMARY: The mortality of hepatocellular carcinoma (HCC) is quickly increasing worldwide. Immunotherapy enables the immune defense of the organism to target liver cancer cells. Recent technologies enable engineering of immune cells, and notably T lymphocytes, to make them more efficient again...

Descripción completa

Detalles Bibliográficos
Autores principales: Rochigneux, Philippe, Chanez, Brice, De Rauglaudre, Bernadette, Mitry, Emmanuel, Chabannon, Christian, Gilabert, Marine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828372/
https://www.ncbi.nlm.nih.gov/pubmed/33450845
http://dx.doi.org/10.3390/cancers13020271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828372/
https://www.ncbi.nlm.nih.gov/pubmed/33450845
http://dx.doi.org/10.3390/cancers13020271

Ejemplares similares